CompletedNot Applicable

Comparing the PiCCO Monitor to the Non-invasive Biobeat (BB)-316PW in ICU Patients

Israel9 participantsStarted 2019-12-26

Plain-language summary

The aim of this study is to compare hemodynamic monitoring using the invasive PiCCO device to the BB-613PW wireless, non-invasive PPG-based device, in critically ill patients within the ICU, suffering from hemodynamic instability and in need of vasopressor support. Data will be gathered prospectively and analysed retrospectively.

Who can participate

Age range18 Years – 99 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * ICU adult patients in the need of vasopressor support of more than 0.2 mcg/Kg/Min for a period longer than 3 hours * Patients in which PiCCO monitoring is needed Exclusion Criteria: * Refusal of the subject * Technical difficulties in insertion of the PiCCO catheters * Significant cardiac arrhythmias * Significant valvular disease * Pregnancy

What they're measuring

Level of accordance between the BB-613PW to the PiCCO

Timeframe: 72 hours per individual

Trial details

NCT IDNCT04215627

SponsorBiobeat Technologies Ltd.

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2021-04-15

View on ClinicalTrials.gov More Critically Ill trials